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Abstract
Background Large-bore aspiration catheters enabling greater flow rates and suction force for mechanical thrombectomy
might improve outcomes in patients with stroke secondary to large-vessel occlusion. Complete or near-complete reperfusion
after a single thrombectomy pass (first-pass effect) is associated with improved clinical outcomes. We assessed the efficacy
and safety of novel MIVI Q™ aspiration catheters in combination with stent-retriever devices.
Methods We retrospectively analyzed demographics, procedure characteristics, and clinical data from consecutive patients
with acute anterior large-vessel occlusion treated with a combined approach using MIVI Q™ aspiration catheters and stent
retrievers. Reperfusion was defined according to the modified thrombolysis in cerebral infarction (mTICI) score. Clinical
outcomes were measured by the National Institute of Health Stroke Scale (NIHSS) and modified Rankin scale (mRS)
scores.
Results We included 52 patients (median age, 75 y IQR: 64–83); 31 (59.6%) women; 14 (26.9%) with terminal internal
carotid artery occlusions, 26 (50%) middle cerebral artery (MCA) segment M1 occlusions, and 12 (23.1%) MCA seg-
ment M2 occlusions; median NIHSS score at admission was 19 (IQR: 13–22). After the first pass, 25 (48%) patients
had mTICI≥ 2c. At the end of the procedure, 47 (90.4%) had mTICI≥ 2b and 35 (67.3%) had mTICI≥ 2c. No serious
device-related adverse events were observed. Symptomatic intracranial hemorrhage developed in 1 patient. Mean NIHSS
score was 13at 24h and 5at discharge. At 90 days, 24 (46.2%) patients were functionally independent (mRS 0–2).
Conclusion This preliminary study found good efficacy and safety for MIVI Q™ aspiration catheters used in combination
with stent-retriever devices.
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Abbreviations
ASPECTS Alberta stroke program early CT score






LTSW Last time seen well
LVO Large-vessel occlusion
MCA Middle cerebral artery
MRS Modified Rankin scale
MTICI Modified thrombolysis in cerebral infarction
scale
NIHSS National Institutes of Health Stroke Scale
PCA Primary combined approach
SAVE Stent-retriever assisted vacuum-locked extrac-
tion
SICH Symptomatic intracranial hemorrhage
TFPE True first-pass effect
TIA Transient ischemic attack
TPA Tissue plasminogen activator
Introduction
Randomized clinical trials have demonstrated the efficacy
of mechanical thrombectomy for acute ischemic stroke
secondary to large-vessel occlusion [1–5]. Mechanical
thrombectomy aims to achieve complete reperfusion, ide-
ally after a single pass of the thrombectomy device through
the occluded segment (termed the first-pass effect, FPE) [6,
7]. The FPE is an independent predictor of good clinical
outcome [8], and the first-pass rate is a metric of technical
success. Modern mechanical thrombectomy devices are
associated with higher reperfusion rates, shorter procedure
times, better clinical outcomes, and lower risk of mortality
[8]; however, although the physical properties influencing
the effectiveness of different large-bore aspiration catheters
have been investigated [9], the superiority of any specific
device over another has yet to be demonstrated in clinical
trials [10].
The MIVI QTM (MIVI Neuroscience, Eden Prairie, MN,
USA) is a novel CE-approved device designed to provide
greater suction and flow [11]. We assessed the technical
efficacy and safety of this new catheter when used in com-
bination with stent-retriever devices in patients with acute
stroke due to anterior circulation large-vessel occlusion.
Methods
Patients
We retrospectively studied consecutive patients with acute
ischemic stroke due to large-vessel occlusion in the anterior
circulation (terminal internal carotid artery or middle cere-
bral artery (MCA) segments M1 or M2, excluding those
with simultaneous cervical carotid and intracranial tandem
occlusions) who were treated with MIVI QTM aspiration
catheters in combination with stent retrievers as the first-
line treatment in a comprehensive stroke center between
June 2019 and May 2020. All thrombectomy procedures
were performed by 4 interventional neuroradiologists, all of
whom had ≥4 years experience in endovascular stroke treat-
ment. The decision to use the MIVI QTM aspiration catheters
as well as the type of stent retriever was at the discretion
of the operator. Inclusion criteria were age ≥18 years, ab-
sence of pregnancy, acute ischemic stroke from large-vessel
occlusion confirmed by computed tomography angiogra-
phy or magnetic resonance angiography, premorbid mod-
ified Rankin scale (mRS) score≤ 2, clinically significant
neurological deficit, defined as assessed National Institutes
of Health Stroke Scale (NIHSS) score≥ 6 and time from
last seen well to treatment ≤24h. Intravenous thrombolysis
was administered before mechanical thrombectomy in all
eligible patients according to established criteria [12]. The
study received institutional review board approval. After
mechanical thrombectomy, patients or their representatives
provided informed consent for imaging, procedural, ana-
lytical, and clinical data to be used in future retrospective
studies. Our institution’s ethics committee waived the need
for further specific informed consent for the current study.
Data Collection
We prospectively recorded age, sex, comorbidities, NIHSS
score at admission and 24h after mechanical thrombectomy,
Alberta stroke program early CT score (ASPECTS) at ad-
mission, site of occlusion, timing of medical and interven-
tional treatments, devices used, reperfusion outcomes, in-
tracranial hemorrhage (ICH) and symptomatic ICH (sICH)
[13] on 24-h follow-up imaging, device-related or tech-
nique-related adverse events, and modified Rankin scale
(mRS) score at day 90.
Outcome Variables
We recorded puncture-to-revascularization time, divided
into puncture-to-first-run time and first-run-to-final-revas-
cularization time. To determine procedural efficacy, an
independent experienced interventional neuroradiologist
blinded to the interventional team’s assessment classified
K
Combined Approach to Stroke Thrombectomy Using a Novel Short Flexible Aspiration Catheter with a Stent Retriever
technical success after a single pass according to the mod-
ified thrombolysis in cerebral infarction (mTICI) scale as
FPE (mTICI≥ 2c) or true FPE (tFPE=mTICI 3) [14, 15],
as well as final reperfusion scores according to the same
criteria.
To determine procedural safety, we analyzed ICH ac-
cording to the European Cooperative Acute Stroke Study-
II definition [13] on computed tomography 24h after the
procedure, early neurological deterioration (≥4 points from
baseline NIHSS 24h after the procedure), clinical compli-
cations deemed procedural by the attending intervention-
ist, and deaths within 30 days attributable to the proce-
dure. Clinical outcomes were assessed by the mRS score at
90 days. Good clinical outcome was defined as mRS≤ 2.
Thrombectomy Technique
The MIVI QTM is a novel aspiration catheter designed to
maximize flow and minimize pressure loss [11]. The prox-
imal three quarters of the catheter shaft have been replaced
with a 119cm 0.02000 stainless steel pusher wire. This inno-
vation allows the full internal area of the guiding catheter
to provide a higher aspirated flow rate and suction force
than standard tubular catheter designs. The outer diameter
(OD) of the proximal segments of the QTM is 0.08800; the
length of the catheter and the inner diameter (ID) of the
distal catheter segments varies according to the model, be-
ing 25cm and 0.06900 for the Q6, 25cm and 0.05700 for the
Q5, 30cm and 0.04300 for the Q4, and 43cm and 0.03600
for the Q3. The aspiration catheter is used with the Super
90 8F guide catheter (MIVI Neuroscience Inc.) (ID 0.09000,
length 80cm, 90cm, or 95cm). Pump aspiration is directly
Fig. 1 a Illustration of the QTM and stent retriever combined approach during the thrombus wedging maneuver. After removing the microcatheter,
the stent retriever has been slightly retracted and the QTM catheter carefully advanced under pump aspiration to ensure better engagement of the
thrombus. The flared proximal tip of the Q catheter (magnified inset) ensures a tight seal between its outer surface and the Super 90 guiding
catheter’s inner surface, enabling increased suction power (curved black dashed arrow) directly through the guide catheter. b Anteroposterior left
internal carotid artery (ICA) angiography through the Super 90 guiding catheter showing a terminal ICA occlusion. c Unsubtracted anteroposterior
view showing the combined approach thrombectomy: Distal end of the Super 90 Catheter (white circle), distal end of a Q6 aspiration catheter
(white arrow), and a fully deployed Aperio® Hybrid stent with its proximal end inside the Q6 (white arrowhead). d Q6 and Aperio® Hybrid with
the “pinned” thrombus
applied to the Super 90 guide catheter and the total system
length varies as the QTM is extended outward and retracted
into the Super 90 guide catheter [11].
Depending on the patient’s condition, procedures were
done with the patient under local anesthesia, conscious se-
dation or general anesthesia. Through femoral artery ac-
cess, the guide catheter was placed in the internal carotid
artery of the affected side. A RebarTM18 microcatheter (ev3
Inc. Medtronic, Minneapolis, MN, USA) with a Synchro®
0.01400 microwire (Boston Scientific for Stryker Neurovas-
cular, Fremont, CA, USA) was advanced through the arte-
rial occlusion. The largest diameter QTM aspiration catheter
that would fit in the affected vessel was advanced to the
occlusion over the microcatheter and microwire unit in
a monorail fashion. Then a stent retriever was advanced
through the microcatheter and deployed at the level of the
thrombus using the push-and-fluff technique [16]. To in-
crease the cross-sectional area and flow, the microcatheter
was removed [17] and pump aspiration was applied to the
guiding catheter. The stent retriever was retracted slightly
and the QTM was carefully advanced until no flow was
present in the aspiration tubing. After 1min under occlu-
sive aspiration, both devices were slowly retrieved as a unit
inside the guiding catheter and then withdrawn while main-
taining aspiration (Fig. 1).
Results
During the 10-month study period, a total of 105 pa-
tients with acute ischemic stroke underwent mechanical
thrombectomy at Hospital Universitari Germans Trias i
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Table 1 Baseline characteristics of the 52 patients included in the
study
Characteristics Values
Age (years) median (IQR) 75 (64–83)
Female sex, n (%) 31 (59.6)
NIHSS score at admission, median (IQR) 19 (13–22)




Medical history, n (%)
Hypertension 34 (65.4)
Diabetes mellitus 15 (28.8)




Myocardial infarction or coronary artery disease 13 (25)
Previous stroke or TIA 8 (15.4)
Anticoagulation 13 (25)
Antiplatelet 9 (17.3)
ASPECTS at admission, median (IQR) 9 (8–10)
Occlusion site, n (%)




Time from symptom onset or LTSW to arterial punc-
ture (min), median (IQR)
278
(170–419)
Door-to-groin time (min), median (IQR) 70 (36–96)





Stent retriever used, n (%)
Aperio Hybrid® 27 (51.9)
Catch View® 15 (28.8)
Embotrap II® 5 (9.6)
NeVa® 5 (9.6)
IV tPA administered, n (%) 17 (32.7)
IQR interquartile range, NIHSS National Institute of Health Stroke
Scale score, mRS modified Rankin Scale score, TIA transient ischemic
attack, ASPECTS Alberta Stroke Program Early CT Score, MCA-
M1 ICA-T: intracranial carotid T occlusion, M1 segment of the mid-
dle cerebral artery, MCA-M2 M2 segment of the middle cerebral
artery, LTSW last time seen well, QTM (MIVI Neuroscience, Inc., Eden
Prairie, MN, USA), Aperio Hybrid® (Acandis company, Pforzheim,
Germany), Catch View® (Balt, Montmorency, France), Embotrap II®
(Cerenovus, Galway, Ireland), NeVa® (Vesalio, Nashville, TN, USA),
IV tPA intravenous tissue plasminogen activator
Pujol comprehensive stroke center. The MIVI QTM aspira-
tion catheter was the first-line treatment in 74 patients with
large-vessel occlusion. Of these, 22 were excluded from the
analyses (13 had posterior circulation occlusions, 4 had tan-
dem occlusions in the cervical internal carotid and MCA,
and 5 had anterior circulation stroke but were treated with
first-line contact aspiration only). Thus, 52 patients were
analyzed. A flowchart of patient selection is provided in
Supplemental Fig. 2. Table 1 summarizes the demographic,
clinical, and procedure characteristics of our cohort.
The QTM aspiration catheter reached the occlusion in all
patients, achieving FPE in 48%. Final reperfusion was ex-
cellent (mTICI≥ 2c) in 67.3% and successful (mTICI≥ 2b)
in 90.4%. No device-related adverse events occurred, and
no patients required rescue therapy. Table 2 reports proce-
dural variables.
Table 3 reports the clinical outcomes related to safety
and efficacy. In one patient with an M1 occlusion, an em-
bolus that had migrated into the A2 segment of the anterior
cerebral artery (unaffected territory) during withdrawal was
retrieved uneventfully with the same system. A patient in
his 40s (admission ASPECTS 5) treated with intravenous
thrombolysis who achieved mTICI 2b after 5 passes devel-
oped sICH and died. In another patient, microwire vessel
perforation during microcatheter advancement (unrelated
to the aspiration catheter or the stent retriever) resulted in
a parenchymal hematoma (PH1), identified at 24h follow-
up, but did not cause any neurological deterioration. Pe-
techial reperfusion hemorrhages (HI1) or minor subarach-
noid hemorrhage occurred in 8 patients.
Early neurological deterioration developed in 7 (13.5%)
patients. A total of 9 (17.3%) patients died before hospital
discharge, 2 from malignant edema related to large-volume
stroke. At 90 days 24 (46.2%) patients were functionally
independent (mRS 0–2).
Discussion
Speed and grade of recanalization are of paramount impor-
tance in neurothrombectomy; therefore, choosing a safe and
time-efficient strategy is key in stroke treatment.
Final reperfusion rates and functional outcomes after
thromboaspiration and stent-retriever thrombectomy are
similar [18]. Used as a stand-alone first-line technique,
stent retrievers achieve better reperfusion with less need
for rescue devices but require longer groin-to-reperfusion
times [18]. Recently introduced approaches combining
stent retrievers and large-bore aspiration catheters trap the
thrombus between the catheter tip and the stent retriever
while maintaining local aspiration [19, 20], a change from
earlier combined approaches (e.g., Solumbra) where the
stent retriever was retracted into the aspiration catheter [21].
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Table 2 Angiographic outcomes




















Time from first angiogram to recanalization
(min), median (IQR)
15 (11–24)
QTM mTICI≥ 2b with a single pass








mTICI≥ 2b, n (%) 34 (65.4)
mTICI 2c-3, n (%) 29 (55.7)








mTICI≥ 2b, n (%) 39 (75)
mTICI 2c-3, n (%) 32 (61.5)








mTICI 3, n (%) 28 (53.8)
mTICI≥ 2b, n (%) 47 (90.4)
mTICI 2c-3, n (%) 35 (67.3)
Total passes, mean 2.46
IQR interquartile range, mTICI modified thrombolysis in cerebral is-
chemia, tFPE mTICI= 3 after a single pass, FPE mTICI≥ 2c after
a single pass
Combined approaches have shown improved reperfusion
rates and FPE [22]; however, there remains considerable
room for improvement in achieving an early and complete
reperfusion [23].
Successful thromboaspiration requires using the largest
catheter that the vessel can accommodate [24–26]. The
Table 3 Clinical efficacy and safety outcomes
Efficacy and safety Results
24-hour NIHSS, mean (IQR) 13 (4–18)
Early neurological improvement, n (%)a 28 (53.8)
NIHSS at discharge, mean (IQR) 5 (1–11)














Intracranial hemorrhage, n (%)
sICH 1 (1.9)
All ICH 10 (19.2)
Early neurological deterioration, n (%) 7 (13.5)
All-cause mortality at 90 days, n (%) 15 (28.8)
In hospital mortality, n (%) 9 (17.3)
Serious device-related adverse events, n (%) 0 (0)
Serious procedure related adverse events, n
(%)b
1 (1.9)
NIHSS National Institute of Health Stroke Scale score, IQR interquar-
tile range, mRS modified Rankin Scale score, sICH symptomatic
intracranial hemorrhage, ICH intracranial hemorrhage
a Early neurological improvement was defined as a reduction of
≥5 points on the NIHSS or an NIHSS score <4 at 24-hours
b Microwire perforation with contrast extravasation on angiography
MIVI Q™ aspiration catheter is designed to maximize lu-
men size, increasing flow rates and tip suction force [11].
Both properties combined have been shown to be necessary
to effectively extract the clot, but in vitro experiments in-
dicated that suction force is more relevant than aspiration
flow in terms of efficacy, particularly in hard clots [27].
The MIVI QTM exhibits these two physical properties, and
especially the aspiration flow rate benefits from a dynamic
effect as in vitro testing has demonstrated that it increases
as the QTM is retracted inside the guiding catheter [11].
It can be used alone or combined with a stent retriever,
as in our cohort. In this preliminary clinical experience,
there were no device-related adverse events, and the an-
giographic, time-metric, and clinical outcomes were sim-
ilar to those in other studies using combined mechanical
thrombectomy approaches [20, 28–30].
Delivering large-bore aspiration catheters intracranially
to the thrombus is not always easy [31] because of vessel
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tortuosity, underlying intracranial atherosclerosis, or even
the anatomical position where the ophthalmic artery orig-
inates from the carotid siphon [32]. The soft and flexible
design of the MIVI Q™ aspiration catheter resulted in ex-
cellent trackability; in all patients, the catheter was navi-
gated to the occlusion uneventfully. These results compare
favorably with those reported in an initial experience with
the Sofia catheter (MicroVention, Tustin, CA, USA), where
the occlusion was reached uneventfully in 96% of cases
[33]. The Q™ catheter was coaxially advanced over the
RebarTM18 microcatheter, and no stent anchoring [34] or
“blind exchange” maneuvers [35] were needed to navigate
the Q™ catheter, even when using larger caliber catheters
and when the arterial anatomy was tortuous. Avoiding an-
choring and exchange maneuver eliminates a theoretical
risk of vascular injury.
The Q™ catheter design takes advantage of fluid me-
chanics theory so that the suction force in the tip of the Q™
catheter increases when it is retrieved inside the guiding
catheter, potentially diminishing the risk of distal emboli
migrating during system retrieval [11]. This may explain
the low rate of complications related to emboli migrating
to previously unaffected territories (1.9%) in our series.
Another potential advantage of the MIVI Q™ aspiration
catheter design is that it does not require a rotating hemo-
static valve connected to a saline flush line, thus enabling
faster preprocedural preparation and faster purging after its
retrieval when additional passes are necessary and thereby
improving the efficiency of interventions.
Our successful reperfusion rate (90.4%) is in line with
those reported by Hesse et al. [30] in the primary com-
bined approach (PCA) group (86%), CAPTIVE (100%)
[20], and SAVE (95%) [28]. Likewise, our rate of final
TICI 3 (53.8%) is in line with those reported in PCA
(37.5%), CAPTIVE (33%), and SAVE (56%). The propor-
tion of procedures that achieved mTICI≥ 2b with a single
pass (53.8%) is in line with rates reported in CAPTIVE
(59%) and SAVE (74%). Our rate of tFPE (42.3%) is sim-
ilar to that reported in SAVE (45%), but higher than that
reported by Hesse et al. [30] (26%), who used the Solumbra
technique [21] for most cases in the PCA group.
Median groin-to-recanalization time was 42min, similar
to that reported in SAVE (34min) [28] and PCA (51min)
[30], but longer than in CAPTIVE (14min) [20].
Lastly, 46.2% of patients in our cohort had good clinical
outcomes (mRS≤ 2) at 90-days, comparable to the 49%
reported in CAPTIVE [20].
In summary, the procedure times and proportion of pa-
tients achieving FPE, tFPE, excellent and successful final
reperfusion and good clinical outcomes at 3 months, were
in line with those reported in other cohorts where combined
approaches were used.
Limitations
This retrospective, non-randomized study included rela-
tively few patients at a single center with no control group,
and reperfusion and clinical outcomes were local operator-
measured; thus, caution is essential in extrapolating the
results. Nevertheless, our preliminary results include the
learning curve inherent in using new devices and merit fur-
ther studies with larger samples to determine the efficacy of
this approach compared to other devices and approaches.
Conclusion
This preliminary study suggests that the MIVI QTM aspira-
tion catheter has a good efficacy and safety profile when
used in combination with stent retrievers, achieving high
reperfusion rates and favorable clinical outcomes.
Supplementary Information The online version of this article (https://
doi.org/10.1007/s00062-021-01065-7) contains supplementary mate-
rial, which is available to authorized users.
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